Risk considerations for the implementation of extended reality solutions within a GxP environment in the biopharma industry
Extended reality (XR) is a term used to encompass different types of immersive technologies that integrate both digital and physical environments. It includes augmented reality (AR), virtual reality (VR), and mixed reality (MR).
XR solutions are often linked to home entertainment and the gaming industry; however, they are becoming more common in the workplace in various industries, including healthcare and biopharma. When implementing this technology in GxP environments, careful thought must be given to the risks associated with deployment.
This paper highlights the risk considerations in different categories based on the appetite of the organization for risk, local country laws, company policies, and IT hardware/software standards. It also includes risk/impact statements to provide context for the risks being considered. The risk considerations are not intended to replace traditional risk assessment but rather to support that process.
The paper aims to help deploy AR/VR technology in biopharma GxP environments. It also gives the areas of risk for IT professionals and users of these technologies at biopharma organizations to consider when developing the technology internally or implementing an off-the-shelf product.
|Risk considerations for the implementation of extended reality solutions within a GxP environment in the biopharma industry June 2023.pdf|
- Download 181
- File Size 341.96 KB
- File Count 1
- Create Date 30th June 2023
- DOI https://doi.org/10.46220/2023IT004
- Last Updated